Edison Liu

2.8k total citations
25 papers, 1.2k citations indexed

About

Edison Liu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Edison Liu has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Edison Liu's work include Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (4 papers) and Acute Myeloid Leukemia Research (3 papers). Edison Liu is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (4 papers) and Acute Myeloid Leukemia Research (3 papers). Edison Liu collaborates with scholars based in United States, Singapore and Germany. Edison Liu's co-authors include Helene S. Smith, Andreas Neubauer, Guoliang Li, Wing‐Kin Sung, B Neubauer, Ekta Khattar, Jianbiao Zhou, Arkasubhra Ghosh, Vinay Tergaonkar and Gaye Saginc and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Genes & Development.

In The Last Decade

Edison Liu

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edison Liu United States 15 730 352 223 200 157 25 1.2k
Charles R. Holst United States 12 840 1.2× 423 1.2× 283 1.3× 235 1.2× 188 1.2× 14 1.4k
Marieke van de Ven Netherlands 20 918 1.3× 625 1.8× 172 0.8× 223 1.1× 121 0.8× 43 1.5k
Evelyne Goillot France 19 1.1k 1.5× 646 1.8× 96 0.4× 213 1.1× 227 1.4× 24 1.7k
Qinxi Li China 22 1.1k 1.5× 287 0.8× 110 0.5× 314 1.6× 193 1.2× 39 1.5k
Natalia Mitin United States 20 1.0k 1.4× 358 1.0× 149 0.7× 127 0.6× 189 1.2× 31 1.5k
Igor Shats Israel 21 1.2k 1.7× 577 1.6× 245 1.1× 510 2.5× 110 0.7× 30 1.8k
Yuji Yaginuma Japan 19 646 0.9× 424 1.2× 59 0.3× 208 1.0× 164 1.0× 51 1.2k
Russell Ericksen United States 14 523 0.7× 305 0.9× 98 0.4× 271 1.4× 144 0.9× 22 1.0k
Emma Hickman United States 12 805 1.1× 605 1.7× 111 0.5× 162 0.8× 236 1.5× 15 1.3k
Sylvia Kaden Germany 16 755 1.0× 319 0.9× 150 0.7× 173 0.9× 379 2.4× 23 1.6k

Countries citing papers authored by Edison Liu

Since Specialization
Citations

This map shows the geographic impact of Edison Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edison Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edison Liu more than expected).

Fields of papers citing papers by Edison Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edison Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edison Liu. The network helps show where Edison Liu may publish in the future.

Co-authorship network of co-authors of Edison Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Edison Liu. A scholar is included among the top collaborators of Edison Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edison Liu. Edison Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menghi, Francesca, Kalyan Banda, Pooja Kumar, et al.. (2023). Abstract PD5-01: PD5-01 Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in triple negative breast cancer and ovarian carcinoma. Cancer Research. 83(5_Supplement). PD5–1. 1 indexed citations
2.
Pan, Chong-xian, Hongyong Zhang, Clifford G. Tepper, et al.. (2015). Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS ONE. 10(8). e0134346–e0134346. 61 indexed citations
3.
Ghosh, Arkasubhra, Gaye Saginc, Shi Chi Leow, et al.. (2012). Telomerase directly regulates NF-κB-dependent transcription. Nature Cell Biology. 14(12). 1270–1281. 303 indexed citations
4.
Győry, Ildikó, Sören Boller, Robert Nechanitzky, et al.. (2012). Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes & Development. 26(7). 668–682. 123 indexed citations
5.
Sandhu, Kuljeet Singh, Guoliang Li, Huay Mei Poh, et al.. (2012). Large-Scale Functional Organization of Long-Range Chromatin Interaction Networks. Cell Reports. 2(5). 1207–1219. 86 indexed citations
6.
Ngamphiw, Chumpol, Anunchai Assawamakin, Shuhua Xu, et al.. (2011). PanSNPdb: The Pan-Asian SNP Genotyping Database. PLoS ONE. 6(6). e21451–e21451. 35 indexed citations
7.
8.
Reinhold, William C., Hosein Kouros‐Mehr, Kurt W. Kohn, et al.. (2003). Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.. PubMed. 63(5). 1000–11. 49 indexed citations
9.
Green, Jeffrey E., Robert D. Cardiff, Lothar Hennighausen, et al.. (2002). Validation of Transgenic Mammary Cancer Models: Goals of the NCI Mouse Models of Human Cancer Consortium and the Mammary Cancer CD-ROM. Transgenic Research. 11(6). 635–636. 3 indexed citations
10.
Mullan, Paul B., Jennifer E. Quinn, Paula M. Gilmore, et al.. (2001). BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents. Oncogene. 20(43). 6123–6131. 127 indexed citations
11.
12.
Neubauer, Andreas, Andreas Burchert, Hans‐Jürgen Gruss, et al.. (1997). Recent Progress On the Role of Axl, A Receptor Tyrosine Kinase, in Malignant Transformation of Myeloid Leukemias. Leukemia & lymphoma. 25(1-2). 91–96. 27 indexed citations
13.
Taylor, Jack A., Yu Li, Mei He, et al.. (1996). p53 mutations in bladder tumors from arylamine-exposed workers.. PubMed. 56(2). 294–8. 37 indexed citations
14.
Zariwala, Maimoona A., Edison Liu, & Yue Xiong. (1996). Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.. PubMed. 12(2). 451–5. 34 indexed citations
15.
Liu, Edison & Bernard E. Weissman. (1993). Oncogenes and tumor suppressor genes. Cancer treatment and research. 63. 1–13. 8 indexed citations
16.
Taylor, Jack A., Yu Li, Ming You, Allen J. Wilcox, & Edison Liu. (1992). B region variant of the estrogen receptor gene. Nucleic Acids Research. 20(11). 2895–2895. 21 indexed citations
17.
Smith, Helene S., Robert Stern, Edison Liu, & Chris Benz. (1991). Early and Late Events in the Development of Human Breast Cancer. PubMed. 57. 329–340. 7 indexed citations
18.
Neubauer, Andreas, B Neubauer, & Edison Liu. (1990). Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interleron gene in chronic myelogeneous leukemia. Nucleic Acids Research. 18(4). 993–998. 68 indexed citations
19.
Nelson, Paul S., Roy A. Frye, & Edison Liu. (1989). Bifunctional oligonucleotide probes synthesized using a novel CPG support are able to detect single base pair mutations. Nucleic Acids Research. 17(18). 7187–7194. 50 indexed citations
20.
Rochlitz, Christoph, Gary K. Scott, James M. Dodson, et al.. (1989). Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer.. PubMed. 49(2). 357–60. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles R. Holst Breakdown of academic impact, for papers by Marieke van de Ven Breakdown of academic impact, for papers by Evelyne Goillot Breakdown of academic impact, for papers by Qinxi Li Breakdown of academic impact, for papers by Natalia Mitin Breakdown of academic impact, for papers by Igor Shats Breakdown of academic impact, for papers by Yuji Yaginuma Breakdown of academic impact, for papers by Russell Ericksen Breakdown of academic impact, for papers by Emma Hickman Breakdown of academic impact, for papers by Sylvia Kaden
Rankless by CCL
2026